Filament Health Logo
About Us
Technology
Why Natural?
Drug Development
Drug Access & Clinical Trials
Social Responsibility
Investors
News
Filament Logo
Sign up for our newsletter
I am interested in
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
About Us
Technology
Why Natural?
Drug Development
Drug Access & Clinical Trials
Social Responsibility
Investors
News
Twitter icon
LinkedIn icon
Instagram icon
YouTube icon
Privacy Policy

Press Release

Red Light Holland Announces New Filament Health PEX010 European Research Shipment

July 16, 2026
News >
Press Release
>
Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Share this post:
Twitter icon
LinkedIn icon
Sign up for our newsletter
Visit:
Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Read the full article

read more News

Press Release

Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp

July 17, 2026
Press Release

Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health

June 18, 2026
Press Release

Red Light Holland's Wholly Owned Subsidiary, Filament Health, Signs Agreement to Supply PEX010 Botanical Psilocybin Drug Candidate for Study at GHU Paris Psychiatrie & Neurosciences in France

June 8, 2026

Sign up for our newsletter

I am interested in
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sitemap
HomeAbout UsTechnologyWhy Natural?Drug DevelopmentDrug Access & Clinical TrialsInvestorsNews
Contact
210-4475 Wayburne Drive
Burnaby, BC  V5G 4X4
General InquiriesMedia InquiriesInvestor InquiriesCareers
Twitter icon
LinkedIn icon
Instagram icon
YouTube icon
Copyright © Filament Health. All rights reserved.
Privacy Policy